HawkScreener
Register Sign In
Dashboard Screener Heatmap Compare Sign In

DOC

Healthpeak Properties, Inc. (NYSE)

Real Estate — REIT - Healthcare Facilities

Healthpeak Properties, Inc. is a Standard & Poor's 500 company that owns, operates, and develops high-quality real estate focused on healthcare discovery and delivery in the United States. Our company was originally founded in 1985. We are organized as an umbrella partnership REIT. We hold substantially all our assets and conduct our operations through our operating subsidiary, Healthpeak OP, a consolidated subsidiary of which we are the managing member. We are a Maryland corporation and qualify as a self-administered REIT. We are headquartered in Denver, Colorado, with additional corporate offices in California, Tennessee, Wisconsin, and Massachusetts and property management offices in several locations throughout the U.S. We have a diversified portfolio of high-quality healthcare properties across three core asset classes of outpatient medical, lab, and continuing care retirement community real estate. Under the outpatient medical and lab segments, we own, operate, and develop outpatient medical buildings, hospitals, and lab buildings. Under the CCRC segment, our properties are operated through RIDEA structures. We have other non-reportable segments that are comprised primarily of: (i) an interest in an unconsolidated joint venture that owns 19 senior housing assets, (ii) loans receivable, and (iii) a preferred equity investment. These non-reportable segments have been presented on a combined basis herein. At September 30, 2025, our portfolio of investments, including properties in certain of our unconsolidated joint ventures, consisted of interests in 703 properties: (i) Outpatient medical – 530 properties; (ii) Lab – 139 properties; (iii) CCRC – 15 properties; and (iv) Other non-reportable – 19 properties. Healthpeak Properties, Inc. was incorporated in 1985 in Maryland, USA.

Buy 2.4 / 5 18 analysts
$21.64
+$0.24 (+1.12%)
Target: $21.44 (-0.9%)
Sign in to add DOC to a watchlist or set price alerts.

Price History

52-Week Range

Fundamentals

Market Cap$14.92B
P/E Ratio (TTM)67.63
Forward P/E2164.00
EPS (TTM)$0.32
Dividend Yield5.64%
Profit Margin7.73%
Revenue Growth7.10%
ROE2.80%
Debt/Equity118.24
Recommendation Buy 2.4
Analyst Target$21.44
Analysts18
Indexes NYSE

Technical Indicators

RSI (14)62.5
Beta1.03
SMA 20-
SMA 40-
52-Week High$21.91
52-Week Low$15.70
50-Day Avg$19.20
200-Day Avg$17.88
Avg Volume$8.87M
Volume$4.66M

Performance Analysis

NEUTRAL

DOC presents a mixed picture with both positive and negative indicators.

- Trading near its 52-week high ($21.91), which may indicate limited upside.
+ RSI at 62.5 shows positive momentum.
+ Price is above both the 50-day and 200-day moving averages — strong uptrend.
- P/E of 67.6 is elevated — the market expects high growth or it may be overvalued.
~ Modest revenue growth of 7.1% year-over-year.
+ Wall Street consensus is "Buy" from 18 analysts.
- Average analyst target of $21.44 implies 0.9% downside.

Recent News

Loading news...
Sign in for full analysis Unlock insider trading data, options chain, news feed, and more.
Sign In

Last updated: Jul 02, 2026 13:06 UTC

Back to Screener Export Report